Parallax Volatility Advisers’s AbbVie ABBV Stock Holding History

Parallax Volatility Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$944K	Sell	4,600 -42,200	-90%	-$9.36M	﹤0.01%	933
2025 Q4	$10.7M	Buy	46,800 +15,600	+50%	+$3.55M	0.02%	435
2025 Q3	$7.22M	Sell	31,200 -70,100	-69%	-$14.3M	0.01%	576
2025 Q2	$18.8M	Sell	101,300 -80,100	-44%	-$14.9M	0.04%	287
2025 Q1	$38M	Sell	181,400 -121,000	-40%	-$23.5M	0.1%	169
2024 Q4	$53.7M	Buy	302,400 +116,900	+63%	+$21.5M	0.1%	151
2024 Q3	$36.6M	Sell	185,500 -47,700	-20%	-$8.9M	0.07%	213
2024 Q2	$40M	Sell	233,200 -39,700	-15%	-$6.58M	0.09%	176
2024 Q1	$49.7M	Sell	272,900 -399,900	-59%	-$68.9M	0.11%	166
2023 Q4	$104M	Buy	672,800 +273,000	+68%	+$39.8M	0.21%	75
2023 Q3	$59.6M	Buy	399,800 +45,800	+13%	+$6.72M	0.13%	129
2023 Q2	$47.7M	Sell	354,000 -4,200	-1%	-$616K	0.1%	164
2023 Q1	$57.1M	Sell	358,200 -6,800	-2%	-$1.04M	0.12%	171
2022 Q4	$59M	Buy	365,000 +81,000	+29%	+$12.4M	0.09%	242
2022 Q3	$38.1M	Sell	284,000 -261,400	-48%	-$37.5M	0.06%	348
2022 Q2	$83.5M	Sell	545,400 -435,400	-44%	-$66.5M	0.08%	168
2022 Q1	$159M	Buy	+980,800	New	+$142M	0.08%	72
2020 Q4	–	Sell	-1,359,672	Closed	-$119M	–	2185
2020 Q3	$119M	Buy	1,359,672 +40,054	+3%	+$3.77M	0.09%	198
2020 Q2	$130M	Buy	1,319,618 +405,718	+44%	+$35.7M	0.15%	108
2020 Q1	$69.6M	Buy	913,900 +685,900	+301%	+$58.4M	0.09%	162
2019 Q4	$20.2M	Buy	228,000 +62,800	+38%	+$5.21M	0.02%	425
2019 Q3	$12.5M	Sell	165,200 -363,700	-69%	-$24.9M	0.01%	530
2019 Q2	$38.5M	Sell	528,900 -565,500	-52%	-$44.4M	0.04%	217
2019 Q1	$88.2M	Buy	1,094,400 +84,500	+8%	+$6.91M	0.1%	94
2018 Q4	$93.1M	Buy	1,009,900 +497,700	+97%	+$43.8M	0.12%	132
2018 Q3	$48.4M	Sell	512,200 -5,300	-1%	-$503K	0.06%	142
2018 Q2	$47.9M	Buy	+517,500	New	+$50.5M	0.07%	126
2018 Q1	–	Sell	-80,000	Closed	-$7.74M	–	2129
2017 Q4	$7.74M	Buy	80,000 +50,000	+167%	+$4.71M	0.01%	480
2017 Q3	$2.67M	Hold	30,000	–	–	﹤0.01%	762
2017 Q2	$2.17M	Sell	30,000 -275,000	-90%	-$18.5M	﹤0.01%	811
2017 Q1	$19.9M	Buy	305,000 +181,000	+146%	+$11.4M	0.04%	243
2016 Q4	$7.76M	Buy	124,000 +75,000	+153%	+$4.58M	0.02%	522
2016 Q3	$3.09M	Sell	49,000 -2,818,400	-98%	-$182M	0.01%	856
2016 Q2	$178M	Buy	2,867,400 +2,790,400	+3,624%	+$170M	0.35%	39
2016 Q1	$4.4M	Buy	77,000 +6,900	+10%	+$385K	0.01%	619
2015 Q4	$4.15M	Sell	70,100 -423,400	-86%	-$24.4M	0.01%	748
2015 Q3	$26.9M	Buy	493,500 +264,500	+116%	+$17.2M	0.06%	217
2015 Q2	$15.4M	Buy	229,000 +224,000	+4,480%	+$14.6M	0.03%	354
2015 Q1	$293K	Buy	+5,000	New	+$302K	﹤0.01%	1854
2014 Q4	–	Sell	-1,900	Closed	-$110K	–	4954
2014 Q3	$110K	Buy	+1,900	New	+$105K	﹤0.01%	2828

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parallax Volatility Advisers's ABBV Position: Q1 2026 in Review

Parallax Volatility Advisers increased its AbbVie (ABBV) stake by 124% in Q1 2026, buying an estimated $2.05M and bringing the position to 16,686 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #673.

Parallax Volatility Advisers first reported a position in ABBV in Q4 2013 and has held it in 32 quarters since. The position peaked at $23.4M in Q4 2018. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Parallax Volatility Advisers held 16,686 shares of AbbVie worth $3.42M as of Q1 2026.
Parallax Volatility Advisers bought 9,251 AbbVie shares in Q1 2026, an estimated $2.05M.
AbbVie made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #673 holding.
Parallax Volatility Advisers first reported a position in AbbVie in Q4 2013 and has held it in 32 quarters since.
Parallax Volatility Advisers's AbbVie position peaked at $23.4M in Q4 2018.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.